183 related articles for article (PubMed ID: 9726485)
1. MR imaging and localized proton MR spectroscopy in late infantile neuronal ceroid lipofuscinosis.
Seitz D; Grodd W; Schwab A; Seeger U; Klose U; Nägele T
AJNR Am J Neuroradiol; 1998 Aug; 19(7):1373-7. PubMed ID: 9726485
[TBL] [Abstract][Full Text] [Related]
2. High-resolution magic angle spinning and 1H magnetic resonance spectroscopy reveal significantly altered neuronal metabolite profiles in CLN1 but not in CLN3.
Sitter B; Autti T; Tyynelä J; Sonnewald U; Bathen TF; Puranen J; Santavuori P; Haltia MJ; Paetau A; Polvikoski T; Gribbestad IS; Häkkinen AM
J Neurosci Res; 2004 Sep; 77(5):762-9. PubMed ID: 15352223
[TBL] [Abstract][Full Text] [Related]
3. Localized proton magnetic resonance spectroscopy of cerebral metabolic disturbances in children with neuronal ceroid lipofuscinosis.
Brockmann K; Pouwels PJ; Christen HJ; Frahm J; Hanefeld F
Neuropediatrics; 1996 Oct; 27(5):242-8. PubMed ID: 8971744
[TBL] [Abstract][Full Text] [Related]
4. MRI and localized proton MRS in early infantile form of neuronal ceroid-lipofuscinosis.
Confort-Gouny S; Chabrol B; Vion-Dury J; Mancini J; Cozzone PJ
Pediatr Neurol; 1993; 9(1):57-60. PubMed ID: 8383973
[TBL] [Abstract][Full Text] [Related]
5. Early differential diagnosis of infantile neuronal ceroid lipofuscinosis, Rett syndrome, and Krabbe disease by CT and MR.
Vanhanen SL; Raininko R; Santavuori P
AJNR Am J Neuroradiol; 1994 Sep; 15(8):1443-53. PubMed ID: 7985561
[TBL] [Abstract][Full Text] [Related]
6. MR-spectroscopy in metachromatic leukodystrophy: A model free approach and clinical correlation.
Feldmann J; Martin P; Bender B; Laugwitz L; Zizmare L; Trautwein C; Krägeloh-Mann I; Klose U; Groeschel S
Neuroimage Clin; 2023; 37():103296. PubMed ID: 36563646
[TBL] [Abstract][Full Text] [Related]
7. Alterations of brain metabolites in metachromatic leukodystrophy as detected by localized proton magnetic resonance spectroscopy in vivo.
Kruse B; Hanefeld F; Christen HJ; Bruhn H; Michaelis T; Hänicke W; Frahm J
J Neurol; 1993 Dec; 241(2):68-74. PubMed ID: 7908027
[TBL] [Abstract][Full Text] [Related]
8. MR imaging and proton MR spectroscopic studies in Sjögren-Larsson syndrome: characterization of the leukoencephalopathy.
Willemsen MA; Van Der Graaf M; Van Der Knaap MS; Heerschap A; Van Domburg PH; Gabreëls FJ; Rotteveel JJ
AJNR Am J Neuroradiol; 2004 Apr; 25(4):649-57. PubMed ID: 15090362
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging and spectroscopic changes in brains of patients with cerebrotendinous xanthomatosis.
De Stefano N; Dotti MT; Mortilla M; Federico A
Brain; 2001 Jan; 124(Pt 1):121-31. PubMed ID: 11133792
[TBL] [Abstract][Full Text] [Related]
10. A metabolomic comparison of mouse models of the Neuronal Ceroid Lipofuscinoses.
Salek RM; Pears MR; Cooper JD; Mitchison HM; Pearce DA; Mortishire-Smith RJ; Griffin JL
J Biomol NMR; 2011 Apr; 49(3-4):175-84. PubMed ID: 21461951
[TBL] [Abstract][Full Text] [Related]
11. MR imaging and proton spectroscopy of neuronal injury in late-onset GM2 gangliosidosis.
Inglese M; Nusbaum AO; Pastores GM; Gianutsos J; Kolodny EH; Gonen O
AJNR Am J Neuroradiol; 2005 Sep; 26(8):2037-42. PubMed ID: 16155156
[TBL] [Abstract][Full Text] [Related]
12. Childhood adrenoleukodystrophy: assessment with proton MR spectroscopy.
Tzika AA; Ball WS; Vigneron DB; Dunn RS; Nelson SJ; Kirks DR
Radiology; 1993 Nov; 189(2):467-80. PubMed ID: 8210375
[TBL] [Abstract][Full Text] [Related]
13. Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS.
Pouwels PJ; Frahm J
Magn Reson Med; 1998 Jan; 39(1):53-60. PubMed ID: 9438437
[TBL] [Abstract][Full Text] [Related]
14. Short echo time proton spectroscopy of human brain using a gradient head coil.
Majors A; Xue M; Ng TC; Modic MT
Magn Reson Imaging; 1992; 10(4):649-54. PubMed ID: 1354323
[TBL] [Abstract][Full Text] [Related]
15. Neuroradiological findings (MRS, MRI, SPECT) in infantile neuronal ceroid-lipofuscinosis (infantile CLN1) at different stages of the disease.
Vanhanen SL; Puranen J; Autti T; Raininko R; Liewendahl K; Nikkinen P; Santavuori P; Suominen P; Vuori K; Häkkinen AM
Neuropediatrics; 2004 Feb; 35(1):27-35. PubMed ID: 15002049
[TBL] [Abstract][Full Text] [Related]
16. 1H-MR spectroscopic detection of metabolic changes in pain processing brain regions in the presence of non-specific chronic low back pain.
Gussew A; Rzanny R; Güllmar D; Scholle HC; Reichenbach JR
Neuroimage; 2011 Jan; 54(2):1315-23. PubMed ID: 20869447
[TBL] [Abstract][Full Text] [Related]
17. Differentiation between portal-systemic encephalopathy and neurodegenerative disorders in patients with Wilson disease: H-1 MR spectroscopy.
Van Den Heuvel AG; Van der Grond J; Van Rooij LG; Van Wassenaer-van Hall HN; Hoogenraad TU; Mali WP
Radiology; 1997 May; 203(2):539-43. PubMed ID: 9114118
[TBL] [Abstract][Full Text] [Related]
18. High resolution 1H NMR-based metabolomics indicates a neurotransmitter cycling deficit in cerebral tissue from a mouse model of Batten disease.
Pears MR; Cooper JD; Mitchison HM; Mortishire-Smith RJ; Pearce DA; Griffin JL
J Biol Chem; 2005 Dec; 280(52):42508-14. PubMed ID: 16239221
[TBL] [Abstract][Full Text] [Related]
19. Neurochemistry of hyponatremic encephalopathy evaluated by MR spectroscopy.
Asaki Y; Murofushi Y; Yasukawa K; Hara M; Takanashi JI
Brain Dev; 2020 Nov; 42(10):767-770. PubMed ID: 32718672
[TBL] [Abstract][Full Text] [Related]
20. Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy.
Kreis R; Ross BD; Farrow NA; Ackerman Z
Radiology; 1992 Jan; 182(1):19-27. PubMed ID: 1345760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
